Daily non-political popular news in brief.
Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
11-09-2007 · EurekAlert!Researchers at Children's Hospital of Pittsburgh of UPMC are participating in an international clinical trial currently underway to study the effectiveness of oral insulin in preventing or delaying the onset of type 1 diabetes in people at risk for the disease.
Read more »
Keywords: children, hospital, studying, drug, potential, prevent, delay, onset, type, diabetes, diabete
« Previous | Next »
Similar news on "Children's Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes":
- Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
09-29-2006 · ScienceDaily
In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
Similar news · Read more »
- Incidence of Fatty Liver Disease rises as obesity in children increases
03-15-2007 · EurekAlert!
As part of a national multicenter research network, Indiana University School of Medicine researchers are looking at Vitamin E and at metformin, a drug used to treat Type II diabetes, as possible therapies for Fatty Liver Disease in 8 to 17 year olds. Fatty Liver Disease may exist in 15 percent or more of obese children.
Similar news · Read more »
- A decisive step toward a cure for insulin dependent diabetes
07-15-2007 · EurekAlert!
Today, a diagnosis of type I diabetes means a life sentence of medical follow-up. The latest study published in the journal Nature by Dr. Constantin Polychronakos, director of the Pediatric Endocrinology Department at the McGill University Health Center, in collaboration with Dr. Hakon Hakonarson, director of the Center for Applied Genomics of the Children's Hospital of Philadelphia, provides hope that this situation will evolve in the long term toward a cure for this disease.
Similar news · Read more »
- St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
08-29-2007 · EurekAlert!
Results of a study by investigators at St. Jude Children’s Research Hospital provide strong evidence for why the targeted therapy drug, imatinib, or Gleevec™, which has revolutionized the treatment of chronic myelogenous leukemia, (CML) is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
Similar news · Read more »
- Study tests oral insulin to prevent type 1 diabetes
06-01-2007 · EurekAlert!
The University of Florida Health Science Center and Shands at UF are among 14 centers in the United States testing oral insulin to prevent or delay type 1 diabetes in people at risk for the disease. The center will work alongside affiliate sites and participating physicians in Type 1 Diabetes TrialNet, a research group dedicated to the understanding, prevention and early treatment of type 1 diabetes.
Similar news · Read more »
- Novel drug preventing protein recycling shows potential for treating leukemia
04-19-2007 · EurekAlert!
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.
Similar news · Read more »
- St. Jude shows gene test not needed if cancer drug given in low doses
06-19-2007 · EurekAlert!
Investigators at St. Jude Children's Research Hospital have shown that when the cancer drug irinotecan is given in low doses for multiple days, it eliminates the need to delay treatment to perform costly genetic testing that determines if the patient is at risk for serious treatment side effects, such as neutropenia.
Similar news · Read more »
- Study tests oral insulin to prevent type 1 diabetes
01-31-2007 · EurekAlert!
Researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in at-risk people, the National Institutes of Health announced today. Type 1 Diabetes TrialNet, an NIH-funded network of researchers dedicated to the understanding, prevention, and early treatment of type 1 diabetes, is conducting the study in more than 100 medical centers across the United States, Canada, Europe and Australia.
Similar news · Read more »
- Common cause of heart disease, diabetes may be treatable with malaria drug
11-07-2006 · EurekAlert!
Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, a common disorder that afflicts as many as one in every four American adults and puts them at sharply increased risk of type 2 diabetes and clogged arteries.
Similar news · Read more »
- New genetic biomarkers could predict coronary heart disease
03-31-2007 · EurekAlert!
New genetic markers may be able to predict whether a person is likely to have coronary heart disease (CAD) in the future. Research shows that people who are pre-diabetic or who have Type 2 diabetes have much shorter telomeres (ends of the chromosome) and, since these people are prone to CAD, an early test could indicate their susceptibility and help them to alter their lifestyle to avoid or delay the onset of the disease.
Similar news · Read more »
